PHARMACOKINETICS OF BUSPIRONE AS DETERMINED BY EXVIVO (3H)-DPAT BINDING

被引:11
作者
SETHY, VH
FRANCIS, JW
机构
关键词
D O I
10.1016/0024-3205(88)90559-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:1045 / 1048
页数:4
相关论文
共 11 条
[1]   SEROTONERGIC MECHANISMS IN THE BEHAVIORAL-EFFECTS OF BUSPIRONE AND GEPIRONE [J].
EISON, AS ;
EISON, MS ;
STANLEY, M ;
RIBLET, LA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1986, 24 (03) :701-707
[2]   METABOLISM AND DISPOSITION OF BUSPIRONE [J].
GAMMANS, RE ;
MAYOL, RF ;
LABUDDE, JA .
AMERICAN JOURNAL OF MEDICINE, 1986, 80 (3B) :41-51
[3]  
GARATTINI S, 1982, J CLIN PSYCHIAT, V43, P19
[4]   IDENTIFICATION OF PRE-SYNAPTIC SEROTONIN AUTORECEPTORS USING A NEW LIGAND - H-3-PAT [J].
GOZLAN, H ;
ELMESTIKAWY, S ;
PICHAT, L ;
GLOWINSKI, J ;
HAMON, M .
NATURE, 1983, 305 (5930) :140-142
[5]   [H-3]8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN BINDING TO PRESYNAPTIC AND POSTSYNAPTIC 5-HYDROXYTRYPTAMINE SITES IN VARIOUS REGIONS OF THE RAT-BRAIN [J].
HALL, MD ;
ELMESTIKAWY, S ;
EMERIT, MB ;
PICHAT, L ;
HAMON, M ;
GOZLAN, H .
JOURNAL OF NEUROCHEMISTRY, 1985, 44 (06) :1685-1696
[6]   A PHARMACOKINETIC PHARMACODYNAMIC RECEPTOR-BINDING MODEL TO PREDICT THE ONSET AND DURATION OF PHARMACOLOGICAL ACTIVITY OF THE BENZODIAZEPINES [J].
JACK, ML ;
COLBURN, WA ;
SPIRT, NM ;
BAUTZ, G ;
ZANKO, M ;
HORST, WD ;
OBRIEN, RA .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1983, 7 (4-6) :629-635
[7]   SELECTIVE INTERACTION OF NOVEL ANXIOLYTICS WITH 5-HYDROXYTRYPTAMINE1A RECEPTORS [J].
PEROUTKA, SJ .
BIOLOGICAL PSYCHIATRY, 1985, 20 (09) :971-979
[8]   SELECTIVE LABELING OF 5-HT1A AND 5-HT1B BINDING-SITES IN BOVINE BRAIN [J].
PEROUTKA, SJ .
BRAIN RESEARCH, 1985, 344 (01) :167-171
[9]   INTERACTION OF TRIAZOLOBENZODIAZEPINES WITH BENZODIAZEPINE RECEPTORS [J].
SETHY, VH ;
RUSSELL, RR ;
DAENZER, CL .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1983, 35 (08) :524-526
[10]   ONSET AND DURATION OF ACTION OF BENZODIAZEPINES AS DETERMINED BY INHIBITION OF (3H)-FLUNITRAZEPAM BINDING [J].
SETHY, VH ;
FRANCIS, JW ;
ELFRING, G .
DRUG DEVELOPMENT RESEARCH, 1987, 10 (02) :117-121